Indian Market Outlook – 27 April 2026

Top indices summary

Index	Closing level (pts)	Change (pts)	% change	Notes
Nifty 50	24,092.70	+194.75	+0.81%	The benchmark bounced back above 24 k after three straight losses and finished near the day’s high. Broader buying across IT, pharma, metal, auto and FMCG stocks drove the rebound.
BSE Sensex	77,303.63	+639.42	+0.83%	Followed a similar trajectory to the Nifty 50. Gains were led by Sun Pharma, Adani Ports, Mahindra & Mahindra, NTPC and TCS.
India VIX (volatility gauge)	≈ 18.7	-5.3%	–	Market volatility cooled; the decline in the VIX signalled easing near‑term fear.

Sectoral performance

Sector index	% change	Observations
Nifty Pharma	≈ +2.8%	Led the market thanks to Sun Pharma’s nearly 7-10 % rally after announcing its US$11.75 billion cash purchase of U.S. drugmaker Organon; the deal gives it access to women’s health drugs and biosimilars, boosting specialty revenues.
Nifty Healthcare	≈ +2.45%	Gains in Sun Pharma and other healthcare names lifted the index.
Nifty IT	≈ +2.0%	IT stocks rebounded sharply after recent sell‑off; TCS, Tech Mahindra, Infosys and HCL Tech rose ~1.5–2.2 % each.
Nifty Metal	≈ +2.0%	Metal producers rallied amid firm global commodity prices.
Nifty Consumer Durables	≈ +2.3%	Stocks such as Amber Enterprises, Voltas, Blue Star and Dixon Technologies jumped on improved demand expectations.
Other sectors	+0.5 – +2%	Auto, FMCG and power indices also closed higher. All 16 major sector indices ended in the green.

Key statistics and market breadth

• Advances vs declines: On the BSE, ~2,977 stocks advanced while around 1 164 declined, indicating strong breadth.
• Trading volume: Heavy turnover was seen in small‑cap counters; many hit the 10 % or 20 % upper circuits.
• Institutional flows (Friday 24 Apr): Foreign institutional investors sold around ₹8,828 crore while domestic institutional investors bought ~₹4,701 crore, demonstrating continued domestic support even as foreigners remained net sellers.
• India VIX: Fell over 5 % to ~18.7, signalling reduced market anxiety after geopolitical tensions eased. The rupee recovered slightly to around ₹94.14 per US dollar.

Top gainers and losers (Nifty 50)

Top gainers	% gain	Drivers
Sun Pharma	+7 – 10%	Announced an all‑cash deal to buy U.S. drugmaker Organon for $11.75 billion (US$14 per share). Analysts said the acquisition gives Sun access to over 70 women’s‑health products and biosimilars, enhancing its specialty‑drugs portfolio and global reach.
Adani Ports	+2.5 – 3%	Benefited from improved risk sentiment and easing geopolitical tensions in the Middle East.
JSW Steel	+2.7%	Supported by firmer metal prices and optimism around China’s stimulus measures.
Mahindra & Mahindra	+2.2%	Positive sentiment after its financial services arm reported a strong profit jump and a hefty dividend proposal.
TCS / Tech Mahindra / Infosys	≈ +1.7 – 2.2%	The IT pack staged a relief rally after last week’s slump; investors used lower valuations to accumulate quality names.

Top losers	% fall	Reasons
Shriram Finance	≈ ‑4%	Profit booking after the NBFC’s Q4 results; the company’s management flagged West‑Asia risks and a potential weak monsoon as headwinds.
Axis Bank	≈ ‑3.5%	Fell after the private lender reported flat net profit (₹7 071 crore) for Q4 due to higher provisions; net interest income grew just 4.7 %, and provisions increased 159 %.
Bharat Electronics (BEL)	≈ ‑1.8%	Profit taking following recent gains; no major negative news.
Coal India	≈ ‑0.8%	Mild weakness ahead of its March‑quarter results (to be released later in the day).
Tata Consumer Products / Bajaj Finance	≈ ‑0.6%	Routine profit booking after recent rally.

Analysis – what moved the market

• Global relief: Reports of potential peace overtures between the U.S. and Iran and the absence of fresh escalation in West Asia improved risk sentiment. U.S. stocks closed at record highs on Friday (S&P 500 +0.8 %, Nasdaq +1.63 %) and most Asian markets were higher on Monday; Japan’s Nikkei hit a new record while South Korea’s Kospi rose 1 %. The positive global cues helped Indian indices gap up at the open.
• Sun Pharma’s mega deal: News of Sun Pharma’s $11.75 billion acquisition of Organon was the day’s biggest catalyst. The stock surged nearly 10 % and pulled the Nifty Pharma and Healthcare indices higher. Analysts see the deal strengthening Sun’s women’s‑health franchise and biosimilar pipeline.
• Rebound in IT stocks: After a week of sharp declines triggered by Infosys’s cautious FY27 outlook, IT majors saw buying interest. Hopes of U.S. rate cuts later in the year and bargain hunting spurred the rally.
• Improving breadth: Mid‑caps and small‑caps outperformed, reflecting risk‑on sentiment. Market breadth (advances vs declines) was robust, and the India VIX fell sharply, indicating reduced volatility expectations.
• Earnings reactions: Axis Bank dropped on a muted quarter; IndusInd Bank (outside Nifty) rallied 6 % after swinging back to profit; Mahindra & Mahindra Financial Services jumped over 9 % after profit doubled. Many stocks moved on Q4 results announcements.
• Crude oil and currency: Brent crude prices hovered above US$107/bbl, and the rupee traded near ₹94.1/US$, but markets largely shrugged off these pressures due to improved risk appetite.

Global cues

• US markets: On Friday 24 Apr, the S&P 500 and Nasdaq Composite hit new highs, while the Dow Jones slipped slightly. Investors awaited the U.S. Federal Reserve’s two‑day policy meeting starting 28 Apr; markets expect rates to remain unchanged, with commentary on inflation and future cuts being the key driver.
• Asia: Japan’s Nikkei 225 closed up ~0.53 % at a record high. South Korea’s Kospi gained ~1 %, while Australia’s ASX 200 slipped 0.54 %. Positive cues from these markets supported sentiment in India.
• Commodities: Brent crude rose ~2.3 % to ~US$107.7 per barrel, and WTI crude near US$96.4/bbl. Higher oil prices could pressure India’s trade balance, but investors focused on the broader risk rally. Gold remained firm as investors hedged geopolitical risks.
• Dollar and Rupee: The US dollar index traded slightly lower near 98.58. The Indian rupee strengthened marginally to ~₹94.14 per US dollar, aided by positive equity flows.

Stocks to watch & corporate updates

Company / stock	Update and reason to watch
Sun Pharmaceutical Industries	Announced an all‑cash deal to acquire Organon & Co. for US$11.75 billion (US$14 per share). The deal is India’s largest pharma acquisition. Sun gains a portfolio of over 70 women’s‑health products, entry into biosimilars and access to markets in China, Brazil and other emerging regions. Its share price rallied 8–10 %.
Reliance Industries (RIL)	Reported Q4 net profit of ₹16,971 crore, down 12.5 % YoY, due to weakness in its oil and chemicals business. Revenue grew to ₹3.03 lakh crore. The stock rose around 1.3 % intraday amid optimism over retail and telecom performance.
Axis Bank	Q4 profit flat at ₹7,071 crore as provisions jumped 159 %. Gross NPA improved to 1.23 %. Shares slid ~3.5 % amid concerns over margin compression.
IndusInd Bank	Swung to a profit of ₹594 crore (vs loss a year ago). NIM improved to 3.39 %. Stock jumped ~6 %.
Shriram Finance	Q4 profit surged 40 % to ₹3 021 crore; management maintained its FY27 AUM growth target of 18 %. Shares fell on profit‑taking and concerns about West‑Asia risks and weak monsoon.
Mahindra & Mahindra Financial Services	Q4 PAT jumped 55 % YoY to ₹873 crore. Board proposed a final dividend of ₹7.50 per share (375 %). Stock rallied over 9 %.
India Cements	Q4 profit surged more than fourfold to ₹59.5 crore due to higher sales volume; stock shot up over 10 %.
L&T Finance	Q4 PAT rose 27 % to ₹807 crore; net interest income improved.
Cohance Lifesciences	Hit the 20 % upper circuit after appointing former Cipla CEO Umang Vohra as Executive Chairman effective 1 May 2026 and Group CEO effective 20 May 2026.
Paytm (One 97 Communications)	Fell over 8 % after the Reserve Bank of India cancelled Paytm Payments Bank’s licence for regulatory violations; management said the action has no material impact on the company.
Upcoming results to watch	Nearly 50 companies were scheduled to announce Q4 results on 27 Apr, including UltraTech Cement, Coal India, Varun Beverages, AU Small Finance Bank, Bajaj Housing Finance, Adani Total Gas, SBI Cards & Payment Services, Phoenix Mills, Nippon Life India Asset Management and others. Their numbers may influence trading on 28 Apr.

Outlook for tomorrow (28 April 2026)

Technical levels:

• Nifty 50: The index reclaimed the 24,000-24,100 zone, which now becomes near‑term support. Analysts see immediate support at 23,800 and 23,550; a breach could trigger a retest of 23,200 (200‑DMA). On the upside, resistance lies at 24,300 and 24,500. The oversold RSI has turned up, suggesting potential for further upside provided global cues remain stable.
• Sensex: Support is near 76 500, while resistance lies around 77,800 – 78,000.
• India VIX: The volatility index near 18–19 suggests complacency. Any spike due to geopolitical news or US Fed commentary could lead to profit‑taking.

Market tone:

• Cautiously bullish: Monday’s broad‑based rally, supported by positive global cues and easing volatility, suggests the market could attempt further upside. However, traders may turn cautious ahead of the U.S. Federal Reserve meeting (28–29 Apr) and a heavy earnings calendar.
• Key triggers: US Fed policy statement and Powell’s commentary on rate outlook, crude oil movement, progress on US–Iran peace talks, Q4 results from key corporates (UltraTech Cement, Coal India, Varun Beverages, etc.), and fresh data on FII/DII flows.
• Strategy: Traders may use dips toward 23,800–23,850 (Nifty) to accumulate quality stocks. Defensive sectors like pharma and FMCG remain in favour due to global uncertainties. Watch for continued strength in IT and metals if global risk appetite persists.

Summary

India’s benchmark indices reversed a three‑day slide on 27 April 2026, with the Nifty 50 closing at 24,092.70 (+0.81 %) and the Sensex at 77,303.63 (+0.83 %). All sectoral indices finished higher, with pharma, healthcare, IT, metal and consumer durables leading gains. Market breadth was robust and the India VIX declined to around 18.7, indicating reduced fear. The rally was propelled by positive global cues, hopes of US‑Iran de‑escalation, and a major acquisition announcement by Sun Pharma, which boosted pharma stocks. IT shares rebounded from oversold levels, and mid‑ and small‑cap indices outperformed. Looking ahead, traders will monitor the U.S. Federal Reserve meeting, crude oil prices, FII/DII flows and a heavy domestic earnings calendar. A cautiously bullish tone is expected, with immediate Nifty support at 23,800 and resistance at 24,300 – 24,500.